Results for the eight participants who received additional treatment during the trial
| Subject | Timing of withdrawal with respect to assessments (between weeks) | Co-intervention | Overall pain in week: | SPADI in week: | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 3 | 6 | 12 | 0 | 3 | 6 | 12 | |||
| SPADI, shoulder pain and disability index. | ||||||||||
| Active | ||||||||||
| Participant 1 | 6–12 | Joint distension | 8 | 8 | 7 | 5 | 50 | 70 | 59 | 53 |
| Participant 2 | 6–12 | Joint distension | 8 | 5 | 6 | 2 | 78 | 62 | 64 | 8 |
| Participant 3 | 6–12 | Second course prednisolone | 8 | 5 | 5 | 2 | 68 | 61 | 61 | 44 |
| Placebo | ||||||||||
| Participant 4 | 0–3 | Prednisolone followed by joint distension | 10 | 3 | 1 | 0 | 74 | 27 | 29 | 2 |
| Participant 5 | 3–6 | Prednisolone | 8 | 8 | 2 | 5 | 80 | 84 | 26 | 46 |
| Participant 6 | 3–6 | Prednisolone | 8 | 9 | 5 | 1 | 63 | 60 | 28 | 7 |
| Participant 7 | 3–6 | Steroid injection followed by joint distension | 8 | 5 | 3 | 2 | 70 | 59 | 25 | 16 |
| Participant 8 | 6–12 | Prednisolone | 9 | 8 | 8 | – | 87 | 78 | 70 | – |